T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQRXW
2076
DELISTED
EQRx, Inc. Warrant
EQRXW
| $535K | ﹤0.01% |
652,353
-4,240
| -0.6% | -$4.1K |
|
2077
B&G Foods
BGS
$291M
| $534K | ﹤0.01% |
32,328
+7,038
| +28% | +$156K |
|
2078
Dillards
DDS
$9.93B
| $534K | ﹤0.01% |
1,956
-954
| -33% | -$252K |
|
2079
Douglas Elliman
DOUG
$184M
| $534K | ﹤0.01% |
136,502
+47,352
| +53% | +$234K |
|
|
INFN
2080
DELISTED
Infinera Corporation Common Stock
INFN
| $534K | ﹤0.01% |
110,235
-1,091,779
| -91% | -$5.98M |
|
2081
Heritage Financial
HFWA
$1.22B
| $533K | ﹤0.01% |
20,103
+2,470
| +14% | +$65.2K |
|
|
SP
2082
DELISTED
SP Plus Corporation
SP
| $533K | ﹤0.01% |
16,996
+1,360
| +9% | +$44.9K |
|
|
SNBR
2083
DELISTED
Sleep Number
SNBR
| $527K | ﹤0.01% |
15,585
-1,337
| -8% | -$53.6K |
|
|
VMEO
2084
DELISTED
Vimeo
VMEO
| $526K | ﹤0.01% |
131,254
-10,833,366
| -99% | -$64M |
|
|
VRE
2085
DELISTED
Veris Residential
VRE
| $526K | ﹤0.01% |
46,241
-14,010
| -23% | -$188K |
|
2086
Wabash National
WNC
$507M
| $526K | ﹤0.01% |
33,772
-3,567
| -10% | -$58.2K |
|
|
VERV
2087
DELISTED
Verve Therapeutics
VERV
| $525K | ﹤0.01% |
+15,255
| New | +$487K |
|
2088
REX American Resources
REX
$1.44B
| $524K | ﹤0.01% |
37,498
-1,535,444
| -98% | -$23.2M |
|
|
KAMN
2089
DELISTED
Kaman Corp
KAMN
| $523K | ﹤0.01% |
18,711
+1,795
| +11% | +$56K |
|
|
MCBC
2090
DELISTED
Macatawa Bank Corp
MCBC
| $522K | ﹤0.01% |
56,353
+1,810
| +3% | +$17K |
|
2091
Veracyte
VCYT
$3.59B
| $521K | ﹤0.01% |
31,334
+298
| +1% | +$6.71K |
|
|
FSR
2092
DELISTED
Fisker Inc.
FSR
| $521K | ﹤0.01% |
68,941
+13,185
| +24% | +$119K |
|
|
KE
2093
Kimball Electronics
KE
$606M
| $520K | ﹤0.01% |
30,269
+2,819
| +10% | +$57.5K |
|
2094
Par Pacific Holdings
PARR
$4.12B
| $520K | ﹤0.01% |
31,678
+3,153
| +11% | +$53.5K |
|
|
GAP
2095
The Gap Inc
GAP
$7.29B
| $520K | ﹤0.01% |
63,259
+17,345
| +38% | +$163K |
|
|
PFC
2096
DELISTED
Premier Financial Corp. Common Stock
PFC
| $520K | ﹤0.01% |
20,212
+8,714
| +76% | +$236K |
|
|
KDNY
2097
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $520K | ﹤0.01% |
+26,426
| New | +$530K |
|
|
BIG
2098
DELISTED
Big Lots, Inc.
BIG
| $519K | ﹤0.01% |
33,191
+1,719
| +5% | +$37K |
|
|
LBAI
2099
DELISTED
Lakeland Bancorp Inc
LBAI
| $519K | ﹤0.01% |
32,367
+9,192
| +40% | +$146K |
|
2100
Innoviva
INVA
$1.5B
| $518K | ﹤0.01% |
44,565
+4,027
| +10% | +$55.2K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.